200 related articles for article (PubMed ID: 35881977)
21. [Autoimmune pancreatitis today: clinical features and diagnostic strategies].
Catanzaro R; Dimartino A
Minerva Gastroenterol Dietol; 2012 Jun; 58(2):151-66. PubMed ID: 22643597
[TBL] [Abstract][Full Text] [Related]
22. Type 2 autoimmune pancreatitis associated with ulcerative colitis.
Nan N; Wang D
Front Immunol; 2023; 14():1288390. PubMed ID: 38124742
[TBL] [Abstract][Full Text] [Related]
23. Correlation of Autoimmune Pancreatitis and Malignancy: Systematic Review and Meta-Analysis.
Haghbin H; Chuang J; Fatima R; Zakirkhodjaev N; Lee-Smith W; Aziz M
Dig Dis Sci; 2022 Jul; 67(7):3252-3264. PubMed ID: 34297267
[TBL] [Abstract][Full Text] [Related]
24. IgG4-related autoimmune pancreatitis-like mass-forming lesion on a background of immune checkpoint inhibitor immunotherapy.
Champion B; Chai SM; Bhandari M; Gunawardena D
Pathology; 2023 Feb; 55(1):133-136. PubMed ID: 35842321
[No Abstract] [Full Text] [Related]
25. Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review.
Fang W; Gao Y; Shi X; Zhang X; Zhou S; Zhu H; Yan W; Wang H
Front Immunol; 2023; 14():1243773. PubMed ID: 37841238
[TBL] [Abstract][Full Text] [Related]
26. Management of Acute Pancreatitis Associated With Checkpoint Inhibitors.
Rogers BB; Cuddahy T; Zawislak C
J Adv Pract Oncol; 2020; 11(1):49-62. PubMed ID: 33542849
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic and Extrapancreatic Features in Autoimmune Pancreatitis.
Kozoriz MG; Chandler TM; Patel R; Zwirewich CV; Harris AC
Can Assoc Radiol J; 2015 Aug; 66(3):252-8. PubMed ID: 25958813
[TBL] [Abstract][Full Text] [Related]
28. Clinical management of autoimmune pancreatitis.
Kamisawa T; Satake K
Adv Med Sci; 2007; 52():61-5. PubMed ID: 18217391
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune Pancreatitis: A Diagnostic Challenge for the Clinician.
Chintanaboina J; Yang Z; Mathew A
South Med J; 2015 Sep; 108(9):579-89. PubMed ID: 26332485
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive therapy management in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors: A case series and systematic literature review.
Wuyts SCM; Cappelle CAH; Verhaert M; Bravenboer B; Aspeslagh S
J Oncol Pharm Pract; 2024 Jan; 30(1):55-66. PubMed ID: 37051622
[TBL] [Abstract][Full Text] [Related]
31. Is autoimmune pancreatitis a risk factor for pancreatic adenocarcinoma?
Kunovský L; Dítě P; Blaho M; Dvořáčková J; Uvírová M; Přecechtělová M; Jabandžiev P; Mašková H; Kianička B; Janeček P; Eid M; Martínek A
Vnitr Lek; 2021; 67(1):9-13. PubMed ID: 33752395
[TBL] [Abstract][Full Text] [Related]
32. Focal IgG4-related autoimmune pancreatitis with distal choledochal adenocarcinoma: a rare case report.
Wang H; Yao L; Wang L; Sun X; Huang B
BMC Gastroenterol; 2021 Nov; 21(1):421. PubMed ID: 34758732
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune chronic pancreatitis.
Kim KP; Kim MH; Song MH; Lee SS; Seo DW; Lee SK
Am J Gastroenterol; 2004 Aug; 99(8):1605-16. PubMed ID: 15307882
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapy.
Dimitriou F; Hogan S; Menzies AM; Dummer R; Long GV
Eur J Cancer; 2021 Nov; 157():214-224. PubMed ID: 34536945
[TBL] [Abstract][Full Text] [Related]
35. Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Zheng Y; Kim R; Yu T; Gayle JA; Wassel CL; Dreyfus J; Phatak H; George S
Oncologist; 2021 Nov; 26(11):e2002-e2012. PubMed ID: 34327774
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic adverse events in patients treated with immune checkpoint inhibitors.
Hana C; Rehman T; Park K; Carracedo Uribe C; Aung PP; Hunis B; Salzberg M; Zikria J; Hussein A
JGH Open; 2023 Mar; 7(3):204-207. PubMed ID: 36968572
[TBL] [Abstract][Full Text] [Related]
37. Acute pancreatitis without abdominal pain induced by administration of nivolumab and ipilimumab.
Yamamoto K; Oka K; Son R; Honda H; Sakae H; Hasegawa K; Horiguchi S; Kato H; Yamasaki O; Otsuka F
Mod Rheumatol Case Rep; 2021 Jul; 5(2):425-430. PubMed ID: 33821775
[TBL] [Abstract][Full Text] [Related]
38. [Autoimmune pancreatitis--treatment and pitfalls in diagnostics].
Rasch S; Phillip V; Weirich G; Esposito I; Gaa J; Schmid RM; Algül H
Internist (Berl); 2014 Oct; 55(10):1231-41. PubMed ID: 25099388
[TBL] [Abstract][Full Text] [Related]
39. Immune checkpoint inhibitor-induced inflammatory arthritis: identification and management.
Williams SG; Mollaeian A; Katz JD; Gupta S
Expert Rev Clin Immunol; 2020 Aug; 16(8):771-785. PubMed ID: 32772596
[TBL] [Abstract][Full Text] [Related]
40. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
